Trial Details 79 Other Sites Washington, Washington, D.C.

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

This study will compare the efficacy and safety of belzutifan + lenvatinib versus cabozantinib in participants with advanced renal cell carcinoma (RCC) with clear cell component after prior therapy. The primary hypothesis is that belzutifan + lenvatinib is superior to cabozantinib in terms of progression-free survival or overall survival.

phase

Phase 3

status

Recruiting

enrollment

708

score

57

start date

2021-02-25

last updated

2022-01-12

biomarkers

N/A

Allentown, Pennsylvania
city distance
~193 miles from Washington, Washington, D.C.
facility
Lehigh Valley Hospital- Cedar Crest-Oncology Clinical Trials ( Site 0056)
1 facility
Recruiting
New Brunswick, New Jersey
city distance
~236 miles from Washington, Washington, D.C.
facility
Rutgers Cancer Institute of New Jersey ( Site 0078)
1 facility
Recruiting
Roanoke, Virginia
city distance
~260 miles from Washington, Washington, D.C.
facility
Blue Ridge Cancer Care - Roanoke ( Site 0043)
1 facility
Recruiting
New York City, New York
city distance
~274 miles from Washington, Washington, D.C.
facility
Memorial Sloan Kettering Cancer Center ( Site 0055)
1 facility
Recruiting
Lake Success, New York
city distance
~293 miles from Washington, Washington, D.C.
facility
Northwell Health- Monter Cancer Center ( Site 0013)
1 facility
Recruiting
Charlotte, North Carolina
city distance
~441 miles from Washington, Washington, D.C.
facility
Levine Cancer Institute ( Site 0004)
1 facility
Recruiting
Burlington, Massachusetts
city distance
~529 miles from Washington, Washington, D.C.
facility
Lahey Hospital & Medical Center ( Site 0090)
1 facility
Recruiting
Burlington, Vermont
city distance
~581 miles from Washington, Washington, D.C.
facility
University of Vermont Medical Center ( Site 0001)
1 facility
Recruiting
Fort Wayne, Indiana
city distance
~610 miles from Washington, Washington, D.C.
facility
Parkview Cancer Institute ( Site 0088)
1 facility
Recruiting
Louisville, Kentucky
city distance
~635 miles from Washington, Washington, D.C.
facility
Norton Cancer Institute - St. Matthews ( Site 0065)
1 facility
Recruiting
Athens, Georgia
city distance
~658 miles from Washington, Washington, D.C.
facility
University Cancer & Blood Center, LLC ( Site 0057)
1 facility
Recruiting
Grand Rapids, Michigan
city distance
~712 miles from Washington, Washington, D.C.
facility
Cancer & Hematology Centers of Western Michigan ( Site 0018)
1 facility
Recruiting
Georgetown University Medical Center ( Site 0006)
(primary contact)

Study Coordinator